← Back to Search

Virus Therapy

COVID 19 Convalescent Plasma for Coronavirus

Phase 1
Waitlist Available
Led By Eric Salazar, MD, PhD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recipient must meet criteria outlined in the recent Investigational COVID-19 Convalescent Plasma - Emergency INDs (investigational new drug) guidance (https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 days post-transfusion
Awards & highlights

Study Summary

This study is evaluating whether convalescent plasma is safe and effective for treating COVID-19.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 days post-transfusion
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 days post-transfusion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cumulative incidence of serious adverse events related to the treatment intervention.
Mortality at Day 28 post-hospital admission.
Secondary outcome measures
Length of ICU stay
Length of hospital stay
Mechanical ventilation
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All subjects recruited will be transfused with COVID 19 convalescent plasma. A prospective comparison with matched historical controls receiving standard care will be employed.

Find a Location

Who is running the clinical trial?

The Methodist Hospital Research InstituteLead Sponsor
270 Previous Clinical Trials
79,908 Total Patients Enrolled
Eric Salazar, MD, PhDPrincipal InvestigatorThe Methodist Hospital Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~70 spots leftby Mar 2025